Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-28 @ 6:27 AM
Study NCT ID:
NCT01787435
Status:
COMPLETED
Last Update Posted:
2015-04-06
First Post:
2013-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acid-suppressing Drugs Pregnancy Asthma Offspring Study
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
A Cohort Study on the Association Between Acid-suppressing Drugs in Pregnancy and Asthma in the Offspring
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is
1. To estimate the association between prenatal exposure to proton pump inhibitors (PPIs) and the risk of asthma during childhood.
2. To estimate the association between prenatal exposure to H2-receptor antagonists (H2RAs) and the risk of asthma during childhood.
1. To estimate the association between prenatal exposure to proton pump inhibitors (PPIs) and the risk of asthma during childhood.
2. To estimate the association between prenatal exposure to H2-receptor antagonists (H2RAs) and the risk of asthma during childhood.
Detailed Description:
A cohort study on the association between acid-suppressing drugs in pregnancy and asthma in the offspring
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: